Kava ban is lifted by EU
Having polished off the last of its supply, the Psychotrophe checked out the usual trusted vendors for some kava products (the 70% CO2 extract, since you ask). Finding that they were all out of stock, and assuming that this meant the half-assed ban introduced in 2002 had started to bite, imagine my surprise at finding the following:
FIJI representatives within the International Kava Executive Council (IKEC) will work on a two- year road map after the ban on kava in the European countries was lifted.
Fiji Kava Council chairman, Ratu Josateki Nawalowalo said the removal of the restriction on kava trade in European countries was a result of a 10-day roundtable consultation between Pacific Island ambassadors, European Commission leaders based in Brussels and the German Government Authorities in Berlin.
Kava trade had been restricted in the European countries since 2002.
Mr Nawalowalo said the recent development on kava would open the way for Pacific island nations to trade with the EU.
"This will involve immediate consultation between aggrieved European pharmaceutical companies and German health authorities 'BfArM' to complete scientific procedures as well as support various applications for alternative kava registration for medicinal drug use, traditional herbal, food beverage as well as GI registration as a protected commodity in Europe," he said.
Not only does the proposal recognise therapeutic use, but also "traditional beverage" - ie intoxicant use. Revolutionary stuff!
|
Recently @ DoseNation
|
|
[link] During the eight-week study, 75 patients with clinically diagnosed Generalised Anxiety Disorder were given Kava or placebo, and anxiety levels were regularly assessed. Results showed a significant reduction in anxiety for the Kava group compared to the placebo group at the end of the study. Kava was well tolerated. Results showed no significant differences across the two groups for liver function which had previously been a concern for Kava's medicinal use. In addition there were no considerable adverse reactions that could be attributed to Kava and no difference in withdrawal or addiction between the groups. This study should be used to overturn the ban law !
[link] During the eight-week study, 75 patients with clinically diagnosed Generalised Anxiety Disorder were given Kava or placebo, and anxiety levels were regularly assessed. Results showed a significant reduction in anxiety for the Kava group compared to the placebo group at the end of the study. Kava was well tolerated. Results showed no significant differences across the two groups for liver function which had previously been a concern for Kava's medicinal use. In addition there were no considerable adverse reactions that could be attributed to Kava and no difference in withdrawal or addiction between the groups. This study should be used to overturn the ban law !
www.aumdoc.com
The comments posted here do not reflect the views of the owners of this site.